Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Down Following Insider Selling

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)’s stock price gapped down before the market opened on Monday following insider selling activity. The stock had previously closed at $8.08, but opened at $7.83. Aveanna Healthcare shares last traded at $8.0480, with a volume of 224,325 shares.

Specifically, CFO Matthew Buckhalter sold 18,340 shares of the stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $143,969.00. Following the completion of the sale, the chief financial officer directly owned 436,980 shares of the company’s stock, valued at $3,430,293. This represents a 4.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Matthew Buckhalter sold 17,289 shares of the firm’s stock in a transaction that occurred on Wednesday, December 31st. The stock was sold at an average price of $8.18, for a total transaction of $141,424.02. Following the sale, the chief financial officer owned 455,320 shares of the company’s stock, valued at approximately $3,724,517.60. This represents a 3.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In other Aveanna Healthcare news, CFO Matthew Buckhalter sold 17,448 shares of the stock in a transaction that occurred on Tuesday, December 30th. The shares were sold at an average price of $8.36, for a total value of $145,865.28. Following the completion of the sale, the chief financial officer owned 472,609 shares in the company, valued at $3,951,011.24. This represents a 3.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on AVAH shares. William Blair assumed coverage on shares of Aveanna Healthcare in a report on Monday, December 8th. They set an “outperform” rating on the stock. BMO Capital Markets assumed coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They set an “outperform” rating and a $11.00 price objective for the company. Zacks Research lowered Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. UBS Group raised their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the stock a “neutral” rating in a research note on Friday, November 7th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $13.00 price target on shares of Aveanna Healthcare in a research note on Friday, December 5th. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Aveanna Healthcare has an average rating of “Hold” and a consensus price target of $10.69.

Aveanna Healthcare Stock Down 0.1%

The company has a market cap of $1.69 billion, a price-to-earnings ratio of 22.38 and a beta of 2.06. The business has a 50-day simple moving average of $8.92 and a two-hundred day simple moving average of $7.52. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The business had revenue of $450.53 million for the quarter. As a group, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Institutional Trading of Aveanna Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of AVAH. Summit Partners L P acquired a new position in Aveanna Healthcare in the 2nd quarter valued at $50,477,000. Vanguard Group Inc. lifted its position in Aveanna Healthcare by 34.7% during the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock worth $35,850,000 after acquiring an additional 1,041,324 shares during the last quarter. AustralianSuper Pty Ltd bought a new stake in Aveanna Healthcare during the third quarter valued at about $15,743,000. Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Aveanna Healthcare by 70.1% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,130,912 shares of the company’s stock valued at $10,031,000 after purchasing an additional 466,022 shares during the last quarter. Finally, Algert Global LLC increased its stake in shares of Aveanna Healthcare by 120.1% in the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock worth $9,070,000 after purchasing an additional 557,898 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.